• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Developing androgen receptor targeting for salivary gland cancers.

作者信息

Ho A L

机构信息

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, USA; Department of Medicine, Weill Cornell Medical College, New York City, USA.

出版信息

Ann Oncol. 2018 Apr 1;29(4):792-794. doi: 10.1093/annonc/mdy042.

DOI:10.1093/annonc/mdy042
PMID:29415170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5913640/
Abstract
摘要

相似文献

1
Developing androgen receptor targeting for salivary gland cancers.开发针对唾液腺癌的雄激素受体靶向治疗。
Ann Oncol. 2018 Apr 1;29(4):792-794. doi: 10.1093/annonc/mdy042.
2
Advanced salivary gland carcinoma expressing androgen receptor and HER2: targeted therapies first?
Ann Oncol. 2020 Jul;31(7):958-959. doi: 10.1016/j.annonc.2020.03.302. Epub 2020 Apr 7.
3
Immunohistochemical demonstration of androgen receptors in human salivary glands.
Arch Oral Biol. 1993 Apr;38(4):299-302. doi: 10.1016/0003-9969(93)90136-a.
4
Is it time to tailor treatments in androgen receptor positive salivary gland cancers?
Oral Oncol. 2023 Jan;136:106274. doi: 10.1016/j.oraloncology.2022.106274. Epub 2022 Dec 12.
5
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.雄激素剥夺疗法对转移性/复发性雄激素受体阳性唾液腺癌患者的临床疗效
Head Neck. 2016 May;38(5):724-31. doi: 10.1002/hed.23940. Epub 2015 Jun 25.
6
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.阿比特龙在挑战两种对雄激素剥夺治疗耐药的 AR 表达唾液腺癌中的活性。
Cancer Biol Ther. 2014 Jun 1;15(6):678-82. doi: 10.4161/cbt.28410. Epub 2014 Mar 11.
7
Immunohistochemical expression of androgen receptor in salivary gland cancers.雄激素受体在唾液腺癌中的免疫组化表达
Pol J Pathol. 2008;59(4):205-10.
8
Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors.唾液腺肿瘤中雄激素、雌激素和孕激素受体的表达。雄激素受体在一部分恶性唾液腺肿瘤中频繁表达。
Am J Clin Pathol. 2003 Jun;119(6):801-6. doi: 10.1309/RVTP-1G0Q-727W-JUQD.
9
Expression of oestrogen progestrone and androgen receptors in salivary gland tumours. A review of literature.
Gulf J Oncolog. 2012 Jan(11):50-9.
10
Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target.唾液腺癌中的雄激素受体：作为一种可能的新靶点的旧标志物的综述。
J Oral Pathol Med. 2018 Aug;47(7):691-695. doi: 10.1111/jop.12741. Epub 2018 Jun 28.

本文引用的文献

1
Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.雄激素受体阳性晚期涎腺导管癌的雄激素剥夺治疗：荷兰35例患者的全国性病例系列研究
Head Neck. 2018 Mar;40(3):605-613. doi: 10.1002/hed.25035. Epub 2017 Dec 22.
2
A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma.一项联合雄激素阻断治疗雄激素受体阳性转移性或局部晚期不可切除涎腺癌患者的前瞻性 II 期研究。
Ann Oncol. 2018 Apr 1;29(4):979-984. doi: 10.1093/annonc/mdx771.
3
Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.转移性和复发性唾液腺癌的全面基因组分析与肿瘤类型相关，并揭示了新的靶向治疗途径。
Ann Oncol. 2017 Oct 1;28(10):2539-2546. doi: 10.1093/annonc/mdx399.
4
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?转移性唾液腺癌的全身治疗：一种病理学驱动的模式？
Oral Oncol. 2017 Mar;66:58-63. doi: 10.1016/j.oraloncology.2016.12.016. Epub 2017 Jan 19.
5
Blockade of Androgen-induced Malignant Phenotypes by Flutamide Administration in Human Salivary Duct Carcinoma Cells.氟他胺对人涎腺导管癌细胞雄激素诱导的恶性表型的阻断作用
Anticancer Res. 2016 Nov;36(11):6071-6075. doi: 10.21873/anticanres.11196.
6
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.复发性和转移性头颈癌的分子图谱：来自精准肿瘤学测序平台的见解
JAMA Oncol. 2017 Feb 1;3(2):244-255. doi: 10.1001/jamaoncol.2016.1790.
7
Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.涎腺导管癌的综合分子特征揭示了可操作的靶点及与乳腺大汗腺癌的相似性。
Clin Cancer Res. 2016 Sep 15;22(18):4623-33. doi: 10.1158/1078-0432.CCR-16-0637. Epub 2016 Apr 21.
8
Integrative clinical genomics of advanced prostate cancer.晚期前列腺癌的整合临床基因组学
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.
9
Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.涎腺导管癌：大汗腺形态的优势、组织学变异的发生率及雄激素受体表达
Am J Surg Pathol. 2015 May;39(5):705-13. doi: 10.1097/PAS.0000000000000413.
10
Abiraterone in metastatic salivary duct carcinoma.转移性涎腺癌中阿比特龙的应用。
J Natl Compr Canc Netw. 2015 Mar;13(3):288-90. doi: 10.6004/jnccn.2015.0040.